BiomEdit, Inc.

BiomEdit, founded in 2022, is a United States-based biotechnology company dedicated to advancing Microbiome Innovation for Animal Health. The company focuses on developing novel probiotics and engineered microbial medicines to tackle crucial challenges in animal agriculture and food security.

Central to BiomEdit's approach is a proprietary platform that combines high-throughput sequencing and data analytics. This technology enables the rapid discovery and screening of innovative probiotic species and bioactive molecules. These discoveries are engineered for properties such as thermostability and improved production of beneficial metabolites, offering antibiotic-free solutions for enhancing animal health.

In its latest funding round, BiomEdit secured a $4.50M grant from the prestigious Bill & Melinda Gates Foundation on 02 November 2023. This investment underscores the potential impact of its innovative solutions and enhances its capability to scale its operations and execute its mission of transforming the animal health sector.